Sign in
TLIS Stock Price, Chart, Stats & News
Talis Biomedical Corporation
Save
Talis Biomedical Corporation (TLIS) does not currently pay a dividend.
5.18M
Market cap
–
Current P/E
–
Forward P/E
TLIS chart
About
Health care
Sector
Medical - Devices
Industry
Talis Biomedical Corporation specializes in molecular diagnostics, focusing on the creation of its Talis One system. This system is being developed to address and resolve existing limitations within current point-of-care diagnostic testing technologies for infectious diseases. The company currently provides the Talis One COVID-19 Test System, which is specifically designed for the detection of SARS-CoV-2, the virus responsible for COVID-19.
Similar securities
Based on sector and market capitalization
Report issue